AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BioMarin PharmaceuticalGenmab A/SUCBGenmab A/SAlnylam Pharmaceuticals
SymbolNASDAQ:BMRNOTCMKTS:GNMSFOTCMKTS:UCBJFNASDAQ:GMABNASDAQ:ALNY
Price Information
Current Price$128.73$342.34$119.75$35.24$160.42
52 Week RangeBuyN/ABuyBuyBuy
Beat the Market™ Rank
Overall Score1.70.40.71.21.5
Analysis Score2.40.00.02.32.4
Community Score3.11.92.33.13.3
Dividend Score0.00.00.00.00.0
Ownership Score1.00.00.00.01.0
Earnings & Valuation Score1.90.01.30.60.6
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$119.70N/AN/A$33.40$151.28
% Upside from Price Target-7.01% downsideN/AN/A-5.22% downside-5.70% downside
Trade Information
Market Cap$23.23 billion$21.12 billion$23.29 billion$22.62 billion$18.65 billion
Beta1.090.670.48N/A1.86
Average Volume1,613,2963,5083,382720,720829,899
Sales & Book Value
Annual Revenue$1.70 billion$804.57 million$5.50 billion$804.57 million$219.75 million
Price / Sales13.6626.254.2328.5984.21
Cashflow$0.64 per share$5.62 per share$5.61 per share$0.55 per shareN/A
Price / Cash200.4360.8921.3564.51N/A
Book Value$17.38 per share$34.13 per share$40.36 per share$3.24 per share$12.90 per share
Price / Book7.4110.032.9710.8812.44
Profitability
Net Income$-23,850,000.00$324.68 million$887.04 million$324.68 million$-886,120,000.00
EPS$0.07N/A$5.82$0.51($8.11)
Trailing P/E Ratio211.0362.7020.5818.95N/A
Forward P/E Ratio74.84∞17.9565.26N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins6.31%41.65%N/A41.69%-310.01%
Return on Equity (ROE)3.62%19.10%N/A19.19%-57.63%
Return on Assets (ROA)2.44%17.83%N/A17.91%-35.70%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.15%0.01%0.14%0.01%0.20%
Current Ratio2.58%19.04%1.38%19.04%4.68%
Quick Ratio1.72%19.04%1.05%19.04%4.48%
Ownership Information
Institutional Ownership Percentage96.46%0.04%N/A4.36%93.42%
Insider Ownership Percentage2.15%N/AN/AN/A3.50%
Miscellaneous
Employees3,0013777,6064191,323
Shares Outstanding180.84 million61.69 million194.51 million652.80 million115.36 million
Next Earnings Date8/6/2020 (Estimated)8/12/2020 (Estimated)7/27/2020 (Confirmed)8/12/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.